MEDICAL FACILITIES CORP on Kanadalainen sairaalapalveluja ja tiloja Yhdysvalloissa tarjoava yritys. Filosofialtaan DR on hieman
erillainen palvelujen tuottaja. Yritys tarjoaa lääketieteen ammattilaisille tilat toimia; lääkärit, fysioterapeutit, hoitajat
ovat yrityksen 'kumpaneita'. Eli MEDICAL FACILITIES CORP johtamia sairaaloita tai terveyskeskuksia ei johdeta perinteisen mallin mukaan.
Tarkemmin voi yritykseen tutustua sen sivuilta:
https://www.medicalfacilitiescorp.ca/
Taloustietoja
Net Income
-4000 -4000 -2000 -2000 0 0 2000 2000 4000 4000 6000 6000 8000 8000 10000 10000 12000 12000 14000 14000 16000 16000 18000 18000 20000 20000 22000 22000 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 6119 38.64335664335664 353.6749791602931 Q32019 -3230 92.31468531468532 437.97029534846513 Q22019 -5283 145.98601398601397 456.4811825165384 Q12019 19963 199.65734265734267 228.85046773564306 Q42018 8007 253.32867132867136 336.6518155103553 Q32018 13050 307.0 291.18157489243345 Q22018 10529 360.67132867132864 313.9121869483091 Q12018 17551 414.34265734265733 250.59828061893228 Q42017 2165 468.013986013986 389.326244558521 Q32017 22124 521.6853146853148 209.36579790115385 Q22017 4739 575.3566433566433 366.1177576756079 Q12017 Net Income Net Income
Total Revenue
0 0 10000 10000 20000 20000 30000 30000 40000 40000 50000 50000 60000 60000 70000 70000 80000 80000 90000 90000 100000 100000 110000 110000 120000 120000 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 102106 36.67972027972027 299.4483708216056 Q32019 100988 87.62377622377622 301.6893529521508 Q22019 99095 138.56783216783214 305.48378870628494 Q12019 123283 189.5118881118881 257.0 Q42018 104207 240.45594405594403 295.237008159463 Q32018 106494 291.3999999999999 290.6528166276591 Q22018 97618 342.34405594405587 308.4443706444023 Q12018 111266 393.2881118881118 281.08755121892784 Q42017 88974 444.23216783216776 325.77089080221305 Q32017 96085 495.1762237762237 311.51720213467576 Q22017 89004 546.1202797202797 325.710757113558 Q12017 Total Revenue Total Revenue
Total Asset
0 0 100000 100000 200000 200000 300000 300000 400000 400000 500000 500000 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 470730 37.73706293706294 285.7314124454679 Q32019 497259 90.14965034965036 273.4239147340501 Q22019 532661 142.56223776223777 257.0 Q12019 481787 194.97482517482516 280.60178063894875 Q42018 469644 247.3874125874126 286.2352362803128 Q32018 473614 299.8 284.3934493334121 Q22018 477357 352.2125874125874 282.65697363007473 Q12018 459588 404.62517482517484 290.90047797755045 Q42017 460407 457.0377622377623 290.5205224335929 Q32017 467856 509.45034965034966 287.0647362956928 Q22017 470806 561.8629370629371 285.6961540555524 Q12017 Total Asset Total Asset
Total liabilities
0 0 40000 40000 80000 80000 120000 120000 160000 160000 200000 200000 240000 240000 280000 280000 320000 320000 Q32019 Q22019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 312567 33.560897435897445 287.2206631380178 Q32019 332337 78.91346153846153 273.5019767648321 Q22019 356118 124.26602564102564 257.0 Q22019 286149 169.61858974358975 305.55249200027475 Q12019 283247 214.97115384615384 307.56623139607575 Q42018 278080 260.32371794871796 311.1516867572417 Q32018 279007 305.6762820512821 310.5084281700923 Q22018 259060 351.0288461538462 324.3499373803065 Q12018 263115 396.3814102564103 321.5361147579864 Q42017 257449 441.73397435897436 325.46783337156614 Q32017 267509 487.0865384615385 318.48705517661176 Q22017 Total liabilities Total liabilit… Total liabilities
Equity
0 0 20000 20000 40000 40000 60000 60000 80000 80000 100000 100000 120000 120000 140000 140000 160000 160000 180000 180000 200000 200000 Q32019 Q22019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 158163 38.04358974358975 318.3586817636588 Q32019 164922 89.45384615384614 310.4204815867855 Q22019 176543 140.86410256410255 296.7720388799583 Q22019 195638 192.274358974359 274.3456544477352 Q12019 186397 243.68461538461537 285.19887353850106 Q42018 195534 295.09487179487184 274.4677986729748 Q32018 198350 346.50512820512824 271.1605088818703 Q22018 200528 397.91538461538465 268.602526934063 Q12018 197292 449.32564102564106 272.403091480943 Q42017 210407 500.73589743589747 257.0 Q32017 203297 552.146153846154 265.35043693705717 Q22017 Equity Equity
ROE(E/I)
-50 -50 -40 -40 -30 -30 -20 -20 -10 -10 0 0 10 10 20 20 30 30 40 40 50 50 60 60 70 70 80 80 90 90 Q32019 Q22019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 25.85 40.605128205128196 281.7132763853349 Q32019 -51.06 95.47692307692306 415.37699556930863 Q22019 -33.42 150.3487179487179 384.72001980015904 Q22019 9.8 205.2205128205128 309.60695331814964 Q12019 23.28 260.09230769230766 286.17974054217814 Q42018 14.98 314.9641025641025 300.60450805260564 Q32018 18.84 369.83589743589744 293.8961221983586 Q22018 11.43 424.70769230769224 306.7741375299572 Q12018 91.13 479.57948717948705 168.2616109539241 Q42017 9.51 534.451282051282 310.1109512191164 Q32017 42.9 589.3230769230768 252.08167565608315 Q22017 ROE(E/I) ROE
ROE(I/E)%
-2 -2 -1 -1 0 0 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 10 10 Q32019 Q22019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 3.87 40.462820512820514 323.81267806267806 Q32019 -1.96 95.14230769230768 430.52991452991455 Q22019 -2.99 149.82179487179485 449.3839031339031 Q22019 10.2 204.5012820512821 207.94301994301995 Q12019 4.3 259.1807692307692 315.94159544159544 Q42018 6.67 313.8602564102564 272.5591168091168 Q32018 5.31 368.5397435897436 297.4537037037037 Q22018 8.75 423.21923076923076 234.4850427350427 Q12018 1.1 477.8987179487179 374.517094017094 Q42017 10.51 532.578205128205 202.2685185185185 Q32017 2.33 587.2576923076923 352.0021367521367 Q22017 ROE(I/E)% ROE%
Dept/equity%
0 0 20 20 40 40 60 60 80 80 100 100 120 120 140 140 160 160 180 180 200 200 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 197.62 38.869930069930064 262.0226704190119 Q32019 201.51 92.85594405594406 257.25725872877865 Q22019 201.72 146.84195804195804 257.0 Q12019 146.26 200.827972027972 324.9408052288778 Q42018 151.96 254.813986013986 317.95806830488567 Q32018 142.22 308.79999999999995 329.88997315395295 Q22018 140.66 362.7860139860139 331.80103799630865 Q12018 129.19 416.77202797202796 345.85226475388583 Q42017 133.36 470.758041958042 340.74384142528106 Q32017 122.36 524.744055944056 354.21929864702025 Q22017 131.59 578.7300699300699 342.9121649964154 Q12017 Dept/equity% Dept/equity
RNV/Equity%
0 0 10 10 20 20 30 30 40 40 50 50 60 60 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 64.56 39.24755244755245 257.0 Q32019 61.23 93.75804195804196 269.7461931655705 Q22019 56.13 148.26853146853148 289.2673899056334 Q12019 63.02 202.77902097902097 262.894635878372 Q42018 55.91 257.2895104895105 290.1094807454009 Q32018 54.46 311.8 295.6596249165952 Q22018 49.22 366.3104895104895 315.716697645601 Q12018 44.38 420.820979020979 334.2426961204842 Q42017 48.7 475.33146853146854 317.7070941759604 Q32017 42.29 529.841958041958 342.24255909827474 Q22017 54.73 584.3524475524476 294.6261497950625 Q12017 RNV/Equity% RNV/Equity%
Equity ration
0 0 10 10 20 20 30 30 40 40 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 33.6 38.190209790209785 319.4794734951506 Q32019 33.17 91.23216783216782 321.8423735481774 Q22019 33.14 144.27412587412584 322.00722704024906 Q12019 40.61 197.31608391608387 280.95870751441134 Q42018 39.69 250.35804195804195 286.01421460460824 Q32018 41.29 303.4 277.2220283607876 Q22018 41.55 356.44195804195806 275.7932980961667 Q12018 43.63 409.48391608391603 264.3634559791998 Q42017 42.85 462.5258741258741 268.6496467730624 Q32017 44.97 515.5678321678322 257.0 Q22017 43.18 568.6097902097903 266.83625836027437 Q12017 Equity ration Equity ration
Current Ration
0 0 0.2 0.2 0.4 0.4 0.6 0.6 0.8 0.8 1 1 1.2 1.2 1.4 1.4 1.6 1.6 1.8 1.8 2 2 2.2 2.2 2.4 2.4 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 1.15 37.283916083916075 385.7059294871795 Q32019 1.14 89.06713286713286 386.73557692307696 Q22019 1.14 140.85034965034964 386.73557692307696 Q12019 1.33 192.6335664335664 367.17227564102564 Q42018 1.75 244.4167832167832 323.92708333333337 Q32018 0.93 296.2 408.3581730769231 Q22018 0.94 347.98321678321673 407.32852564102564 Q12018 1.31 399.76643356643353 369.23157051282055 Q42017 2.4 451.54965034965034 257.0 Q32017 2.26 503.3328671328671 271.41506410256414 Q22017 2.36 555.1160839160838 261.1185897435897 Q12017 Current Ration Current Ration
Working Capital TurnOver
-12 -12 -10 -10 -8 -8 -6 -6 -4 -4 -2 -2 0 0 2 2 4 4 6 6 Q32019 Q22019 Q12019 Q42018 Q32018 Q22018 Q12018 Q42017 Q32017 Q22017 Q12017 6.13 36.75524475524475 108.0343062469889 Q32019 6.87 87.8041958041958 98.49018387666615 Q22019 6.24 138.85314685314685 106.61558535410313 Q12019 3.71 189.9020979020979 139.246165890477 Q42018 2.02 240.951048951049 161.0428777902682 Q32018 -11.7 292.0 337.9960655211177 Q22018 -12.29 343.048951048951 345.60556849205074 Q12018 2.63 394.0979020979021 153.1754255660832 Q42017 1.27 445.1468531468532 170.71597478721696 Q32017 1.22 496.1958041958042 171.36084792034688 Q22017 1.57 547.2447552447552 166.84673598843747 Q12017 Working Capital TurnOver Working Capita… Working Capital TurnOver
Historiallisia kommenteja.
9.11.2019
Yhtiö päätti laskea osingoaan ja muuttaa se kvartaalipohjaiseksi. Olin toivonut, että näin ei tapahtuisi, mutta toiveet
harvoin toteutuvat. Ostan yhtiön osakkeita lähitulevaisuudessa kuitenkin lisää, koska nyt yhtiö on lisätty ns. tullaan myymään
tulevaisuudessa, kun yhtiön markkinakurssin arvo löytää ostojen jälkeen sopivan tason. Uskoisin kurssin nousevan vuoden kahden kuluttua.
13.8.2019
Kahden peräkkäisen kvartaalin negatiivinen tulos aiheutti varsinaisen syöksylaskun yhtiön osakkeen arvoon, jonka seurauksena
yhtiön dividend yield nousi tuntuvasti. Yhtiötä olisi todella houkuttelevaa ostaa, mutta vaikka luulen ettei osinkotuottoa
tulla juuri muuttamaan tulevaisuudessa, niin katson kuitenkin kolmannen kvartaalin tuloksen ennen kuin lisään tällä yhtiöllä
painoa salkussani.
